Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Bone mineral density in women with rheumatoid arthritis: A link between immune and biochemical markers].

Autor: Dobrovolskaya OV; Nasonova Research Institute of Rheumatology., Demin NV; Nasonova Research Institute of Rheumatology., Kozyreva MV; Nasonova Research Institute of Rheumatology., Samarkina EY; Nasonova Research Institute of Rheumatology., Diatroptov ME; Nasonova Research Institute of Rheumatology., Toroptsova NV; Nasonova Research Institute of Rheumatology.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2024 Jun 03; Vol. 96 (5), pp. 494-499. Date of Electronic Publication: 2024 Jun 03.

Putative Association between Low Baseline Gene Expression in the Peripheral Blood and Clinical Remission in Rheumatoid Arthritis Patients Treated with Tofacitinib.

Autor: Tchetina EV; Immunology and Molecular Biology Laboratory, Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia., Satybaldyev AM; Early Rheumatoid Arthritis Department, Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia., Markova GA; Immunology and Molecular Biology Laboratory, Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia., Samarkina EY; Immunology and Molecular Biology Laboratory, Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia., Lila AM; Early Rheumatoid Arthritis Department, Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia.

Publikováno v: Life (Basel, Switzerland) [Life (Basel)] 2021 Dec 11; Vol. 11 (12). Date of Electronic Publication: 2021 Dec 11.

Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated according to the principle of "Treat to target" (REMARKA study).

Autor: Guseva IA; Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova», Moscow, Russia., Smirnov AV; Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova», Moscow, Russia., Demidova NV; Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova», Moscow, Russia., Krylov MY; Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova», Moscow, Russia., Avdeeva AS; Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova», Moscow, Russia., Samarkina EY; Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova», Moscow, Russia., Luchikhina EL; Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russia., Karateev DE; Moscow Regional Research and Clinical Institute (MONIKI), Moscow, Russia., Abramov DD; National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia, Moscow, Russia., Nasonov EL; Federal State Budgetary Scientific Institution «Research Institute of Rheumatology named after V.A. Nasonova», Moscow, Russia.; Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2018 May 11; Vol. 90 (5), pp. 38-43.